Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis.

Scientific reports·2026
Same author

Tocilizumab for severe and refractory mucous membrane pemphigoid.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Incidence and Mortality of Mucous Membrane Pemphigoid in France.

The British journal of dermatology·2026
Same author

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.

The Journal of infectious diseases·2026
Same author

Premature hair greying in patients with pulmonary fibrosis and relatives is suggestive of pathogenic variants in telomere related genes.

The European respiratory journal·2026
Same author

Offer of a menu of different nicotine substitute products to REduce Tobacco Use iN pEople living with HIV (RETUNE): a protocol for a pragmatic randomized trial within the Swiss HIV Cohort Study.

Trials·2026

Related Experiment Video

Updated: Jun 10, 2026

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

Characteristics, design, and statistical methods in platform trials: a systematic review.

Clément R Massonnaud1, Christof Manuel Schönenberger2, Malena Chiaborelli2

  • 1Université Paris Cité, Inserm, IAME, Paris F-75018, France; AP-HP, Hôpital Bichat, Département d'Épidémiologie, Biostatistique et Recherche Clinique, Paris F-75018, France.

Journal of Clinical Epidemiology
|May 11, 2025
PubMed
Summary

Platform trials (PTs) are increasingly popular in clinical research, featuring diverse methodologies. Enhancing transparency in complex Bayesian PTs is crucial for reliability and acceptance.

Keywords:
Adaptive clinical trialsAdaptive platform trialsBayesian designsBayesian trialsPlatform trialsSystematic review

More Related Videos

Postural Organization of Gait Initiation for Biomechanical Analysis Using Force Platform Recordings
06:21

Postural Organization of Gait Initiation for Biomechanical Analysis Using Force Platform Recordings

Published on: July 26, 2022

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis
07:12

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis

Published on: February 10, 2026

Related Experiment Videos

Last Updated: Jun 10, 2026

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

Postural Organization of Gait Initiation for Biomechanical Analysis Using Force Platform Recordings
06:21

Postural Organization of Gait Initiation for Biomechanical Analysis Using Force Platform Recordings

Published on: July 26, 2022

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis
07:12

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis

Published on: February 10, 2026

Area of Science:

  • Clinical Research
  • Biostatistics
  • Epidemiology

Background:

  • Platform trials (PTs) offer innovative and flexible methodologies gaining traction in clinical research.
  • The study aimed to characterize the evolving landscape of PTs.

Purpose of the Study:

  • To determine the characteristics, methodological approaches, and statistical practices employed in platform trials.
  • To analyze trends in PT initiation and design.

Main Methods:

  • A systematic search of trial registries and bibliographic databases identified 189 eligible platform trials.
  • Data extraction focused on trial status, design features, statistical methods, and reporting quality.
  • Eligible PTs were randomized controlled trials with multiple interventions in a single population, allowing arm flexibility.

Main Results:

  • Infectious diseases and oncology were the primary focus areas for PTs, with a significant number related to COVID-19.
  • Bayesian designs were prevalent, with 23% of trials lacking a predetermined sample size, often designated as perpetual trials.
  • Frequentist PTs more commonly predetermined interim analyses, while Bayesian PTs extensively utilized simulations, though code sharing was minimal.

Conclusions:

  • Platform trials remain a popular and diversifying research modality.
  • Improved transparency and reporting, particularly for complex Bayesian designs, are vital for ensuring the reliability and acceptance of platform trials.